Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097064202
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
12/17/2025
Active Ingredients
EMTRICITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA091168On Market Since
8/31/2020
Pharmacological Classes
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
NEVIRAPINE 200 MG TABLET
Generic
65862002760•Aurobindo Pharma Limited
$0.1314
per EA
AZATHIOPRINE 50 MG TABLET
Generic
16571083501•Rising Pharma Holdings Inc.
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
60219107601•Amneal Pharmaceuticals NY LLC
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
67877049301•Ascend Laboratories, LLC
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
67877049305•Ascend Laboratories, LLC
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68084022901•American Health Packaging
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68382000301•Zydus Pharmaceuticals (USA) Inc.
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68382000305•Zydus Pharmaceuticals (USA) Inc.
$0.1334
per EA
AZATHIOPRINE 50 MG TABLET
Generic
68462050201•Glenmark Pharmaceuticals Inc., USA
$0.1334
per EA
NEVIRAPINE 200 MG TABLET
Generic
00378405091•Mylan Pharmaceuticals Inc.
$0.1472
per EA